Transoral endoscopic thyroidectomy vestibular approach (TOETVA). Recommendations of the AFCE (Francophone Association of Endocrine Surgery) with the SFE (French Society of Endocrinology) and the SFMN (French Society of Nuclear Medicine)

J Visc Surg. 2023 Jun;160(3S):S130-S133. doi: 10.1016/j.jviscsurg.2023.04.014. Epub 2023 May 15.

Abstract

Transoral endoscopic thyroidectomy vestibular approach (TOETVA) can be proposed for selected patients with a thyroid volume<45mL and/or a nodule<4cm (for Bethesda category II, III or IV lesions), or<2cm (for Bethesda category V or VI lesions), with no suspicion of lateral nodal involvement or mediastinal extension who wish to avoid a cervical scar. Such patients should have satisfactory dental status, have been educated on the specific risks of the transoral route and the need for perioperative oral care, and also fully informed regarding the lack of proof of TOETVA effectiveness in terms of quality of life and patient satisfaction. The patient should be made aware of the possibility of postoperative pain in the neck cervical and chin, which may persist for several days to a few weeks after the intervention. Transoral endoscopic thyroidectomy should be performed in centers with expertise in thyroid surgery.

Keywords: Thyroidectomy; Transoral endoscopic thyroidectomy vestibular approach (TOETVA).

Publication types

  • Review

MeSH terms

  • Endoscopy
  • Humans
  • Natural Orifice Endoscopic Surgery*
  • Nuclear Medicine*
  • Quality of Life
  • Thyroid Gland / surgery
  • Thyroidectomy / adverse effects